What sector does Design Therapeutics, Inc. Common Stock (DSGN) operate in?
Design Therapeutics, Inc. Common Stock belongs to the Healthcare sector and operates in the Biotechnology industry.
What is Design Therapeutics, Inc. Common Stock (DSGN) current stock price?
As of the latest data, Design Therapeutics, Inc. Common Stock stock price is $12.64, with a previous close of $12.35. Design Therapeutics, Inc. Common Stock gained $0.29 in the last trading session, representing a 2.35% increase.
What is Design Therapeutics, Inc. Common Stock (DSGN) current market capitalization?
Design Therapeutics, Inc. Common Stock market cap is approximately 720.02 million.
What is Design Therapeutics, Inc. Common Stock (DSGN) Earnings Per Share (EPS)?
The trailing EPS is -$1.19, and the forward EPS is -$1.71.
What is Design Therapeutics, Inc. Common Stock (DSGN) EBITDA?
Design Therapeutics, Inc. Common Stock EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is -22.81 million.
Does Design Therapeutics, Inc. Common Stock (DSGN) pay dividends?
No. Design Therapeutics, Inc. Common Stock does not pay a dividend.
When is Design Therapeutics, Inc. Common Stock (DSGN) next earnings report?
Design Therapeutics, Inc. Common Stock is expected to release its next earnings report on March 31, 2026.
What is Design Therapeutics, Inc. Common Stock (DSGN) beta (volatility) score?
Design Therapeutics, Inc. Common Stock has a beta of 1.634, suggesting it is more volatile than the market.